Epinephrine self-injectable - Shionogi Pharma
Alternative Names: Adrenaclick; TwinjectLatest Information Update: 27 Apr 2024
At a glance
- Originator Verus Pharmaceuticals
- Developer Endo, Inc.; Shionogi Pharma
- Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaphylaxis; Hypersensitivity
Most Recent Events
- 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 07 Jan 2010 Launched for Anaphylaxis in USA (SC)